Arrowhead Pharmaceuticals, Inc. (0HI3.L)
USD 21.69
(-2.58%)
USD 21.69
(-2.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 240.73 Million | 243.23 Million | 138.28 Million | 87.99 Million | 168.79 Million | 16.14 Million |
| Cost of Revenue | - | 10.42 Million | - | - | - | - |
| Gross Profit | 240.73 Million | 232.81 Million | 138.28 Million | 87.99 Million | 168.79 Million | 16.14 Million |
| Operating Expenses | 445.73 Million | 421.73 Million | 287.32 Million | 181.15 Million | 107.6 Million | 72.07 Million |
| Selling, General and Administrative Expenses | 90.93 Million | 124.43 Million | 80.98 Million | 52.27 Million | 26.55 Million | 19.11 Million |
| Research and Development Expenses | 353.18 Million | 297.3 Million | 206.34 Million | 128.87 Million | 81.04 Million | 52.96 Million |
| Other Expenses | 1.61 Million | 5.79 Million | 2.07 Million | -582.52 Thousand | - | 7493.00 |
| Cost and Expenses | 445.73 Million | 421.73 Million | 287.32 Million | 181.15 Million | 107.6 Million | 72.07 Million |
| Operating Income | -205 Million | -178.5 Million | -149.03 Million | -93.15 Million | 61.19 Million | -55.93 Million |
| Interest Expense | 18.32 Million | 5.03 Million | 6.12 Million | 9.19 Billion | 6.95 Billion | 1.04 Billion |
| Income Tax Expense | 2.78 Million | 3.78 Million | 2000.00 | 2400.00 | 173.55 Thousand | 2400.00 |
| Earnings before Tax | -206.49 Million | -172.7 Million | -140.84 Million | -84.55 Million | 68.14 Million | -54.44 Million |
| Net Income | -205.27 Million | -176.49 Million | -140.84 Million | -84.55 Million | 67.97 Million | -54.45 Million |
| Earnings Per Share Basic | -1.91 | -1.67 | -1.36 | -0.84 | 0.72 | -0.65 |
| Earnings Per Share Diluted | -1.92 | -1.67 | -1.36 | -0.84 | 0.69 | -0.65 |
| Weighted Average Shares Outstanding | 107.31 Million | 105.42 Million | 103.74 Million | 100.72 Million | 93.85 Million | 83.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 106.75 Million | 105.42 Million | 103.74 Million | 100.72 Million | 98.6 Million | 83.63 Million |
| Gross Margin | 1.00 | 0.96 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -0.73 | -0.73 | -1.02 | -0.99 | 0.39 | -3.20 |
| Profit Margin | -0.85 | -0.73 | -1.02 | -0.96 | 0.40 | -3.37 |
| EBITDA | -175.67 Million | -162.28 Million | -132.58 Million | -87.21 Million | 65.62 Million | -51.23 Million |
| Earnings Before Tax Margin | -0.85 | -0.73 | -1.08 | -1.06 | 0.36 | -3.47 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 3.55 Million | 240.73 Million | 16.09 Million | 15.82 Million |
| Cost of Revenue | 4.78 Million | 4.52 Million | 4.26 Million | 12.49 Million | 3.85 Million | 3.27 Million |
| Gross Profit | -4.78 Million | -4.52 Million | -712 Thousand | 228.24 Million | 12.23 Million | 12.55 Million |
| Operating Expenses | 171.35 Million | 121.66 Million | 140.09 Million | 445.73 Million | 124.42 Million | 118.52 Million |
| Selling, General and Administrative Expenses | 23.19 Million | 24.64 Million | 23.19 Million | - | 24.16 Million | 23.36 Million |
| Research and Development Expenses | 148.16 Million | 97.02 Million | 116.49 Million | - | 99.85 Million | 94.75 Million |
| Other Expenses | 760 Thousand | 189 Thousand | 421 Thousand | 1.53 Million | 717 Thousand | 306 Thousand |
| Cost and Expenses | 176.14 Million | 126.19 Million | 140.09 Million | 445.73 Million | 124.42 Million | 118.52 Million |
| Operating Income | -176.14 Million | -126.19 Million | -136.54 Million | -205 Million | -108.33 Million | -102.7 Million |
| Interest Expense | 5.09 Million | 7.24 Million | 5.36 Million | 18.32 Million | 5.26 Million | 5.15 Million |
| Income Tax Expense | -3.18 Million | -1.69 Million | -3.31 Million | 2.78 Million | 2.02 Million | 742 Thousand |
| Earnings before Tax | -173.97 Million | -126.99 Million | -138.68 Million | -206.49 Million | -108.99 Million | -103.38 Million |
| Net Income | -170.79 Million | -125.3 Million | -132.86 Million | -205.27 Million | -109.67 Million | -102.94 Million |
| Earnings Per Share Basic | -1.38 | -1.02 | -1.24 | - | -1.02 | -0.96 |
| Earnings Per Share Diluted | -1.38 | -1.02 | -1.24 | - | -1.02 | -0.96 |
| Weighted Average Shares Outstanding | 124.19 Million | 123.28 Million | 107.41 Million | 106.75 Million | 107.31 Million | 107 Million |
| Weighted Average Shares Outstanding (Diluted) | 124.19 Million | 123.28 Million | 107.41 Million | 106.75 Million | 107.31 Million | 107 Million |
| Gross Margin | - | - | -0.20 | 0.95 | 0.76 | 0.79 |
| EBIT Margin | - | - | -36.34 | - | -6.20 | -6.00 |
| Profit Margin | - | - | -37.42 | -0.85 | -6.81 | -6.51 |
| EBITDA | -171.35 Million | -121.66 Million | -129.05 Million | - | -99.86 Million | -94.94 Million |
| Earnings Before Tax Margin | - | - | -38.45 | -0.85 | -6.73 | -6.49 |
FF
601615
VGPBF
NWBO
002942
MYCR